Introduction {#s1}
============

*Cannabis sativa* (or cannabis) is the most widely used drug in the world ([@CIT0026]). The primary psychoactive ingredient in cannabis, Δ^9^-tetrahydrocannabinol (THC), binds to CB~1~ receptors in the brain and produces a variety of acute effects, including subjective feelings of sedation and euphoria ([@CIT0015]). Consistent with the role of the endogenous cannabinoid system in the regulation of anxiety and fear learning ([@CIT0005]), THC and other CB~1~ agonists have also been shown to modulate subjective anxiety ([@CIT0030]) and facilitate the extinction of fear responses ([@CIT0022]).

The effects of THC on anxiety and fear may be due to changes in amygdala reactivity. CB~1~ receptors are expressed at high levels in the amygdala, and activation of CB~1~ receptors can attenuate anxiety responses and amygdala activation to aversive stimuli ([@CIT0023]). Additionally, in humans, acute low-dose administration of THC ([@CIT0020]) and higher levels of daily cannabis use ([@CIT0006]) are associated with decreased threat-related amygdala reactivity. Frequent cannabis users also exhibit reduced amygdala activation to anger stimuli relative to healthy controls ([@CIT0012]). [@CIT0014] further found that increased endocannabinoid signaling is associated with decreased threat-related amygdala activation. Taken together, THC may inhibit amygdala reactivity to threatening stimuli.

Given that the brain is organized into interconnected networks ([@CIT0027]), it is possible that THC also impacts the functional coupling between the amygdala and other regions of the brain, specifically, the prefrontal cortex (PFC). The amygdala has strong reciprocal connections with the PFC ([@CIT0009]), and dynamic interactions between these regions are necessary for the recognition and modulation of affective states, including fear and anxiety ([@CIT0002]; [@CIT0021]). Prior studies have demonstrated that exposure to threat ([@CIT0010]) and administration of anxiolytic substances, such as alcohol and oxytocin ([@CIT0011]; [@CIT0022]), modulate amygdala-PFC functional coupling. It has also been demonstrated that acute THC administration increases PFC perfusion at baseline ([@CIT0028]), which could subsequently impact the way fear stimuli are processed and how the PFC and amygdala functionally interact.

To date, few studies have investigated the acute effects of THC on amygdala functional connectivity. In one, [@CIT0018] reported that THC reduced functional connectivity between the amygdala and the primary sensorimotor areas during aversive pain states. In a separate study, [@CIT0008] found that cannabidiol, another cannabis derivative, but not THC, disrupted connectivity between the amygdala and the anterior cingulate cortex (ACC) during the viewing of threatening faces.

Notably, however, the amygdala is not a single, uniform structure. The human amygdala can be separated into at least 3 structurally and functionally distinct subregions: basolateral (AMYG-BL), centromedial (AMYG-CM), and superficial (AMYG-SF) ([@CIT0001]). These subregions have different patterns of functional connectivity ([@CIT0001]) and are part of distinct socio-emotional networks: aversion (AMYG-BL), affiliation (AMYG-CM), and perception (AMYG-SF) ([@CIT0003]). Broadly, the AMYG-BL and AMYG-SF are implicated in fear detection and perception, whereas the AMYG-CM is responsible for behavioral and autonomic outputs of fear expression ([@CIT0004]). Given these differences, it is critical to examine the potentially unique and shared THC-inducted patterns of functional connectivity across subregions.

The aim of the current study was to conduct a more nuanced analysis of existing functional magnetic resonance imaging (fMRI) data on the neural effects of THC in healthy adults ([@CIT0020]). The study was a 2-session (placebo vs THC), double-blind, within-subjects design. Our prior analyses indicated that THC attenuated amygdala reactivity to threatening faces (ie, angry and fearful). In the present study, we employed a generalized form of context-dependent psychophysiological interaction analyses (gPPIs; [@CIT0019]), using each amygdala subregion as the seed region of interest, to determine the effects of THC on amygdala-PFC functional connectivity during the viewing of angry and fearful faces. Given that our task (ie, viewing threatening faces) probed fear perception, we hypothesized that THC would modulate functioning coupling between the AMYG-BL and AMYG-SF and the PFC, as these two amygdala subregions are most relevant for detecting threat and extracting information from social stimuli.

Methods {#s2}
=======

Participants {#s3}
------------

Sixteen right-handed healthy volunteers (50% male; ages 18--28; *M* age=20.8 years \[SD=2.6\]) were included in the study (see [@CIT0020] for complete description). All participants had used marijuana at least 10 times in their lives, but none were daily marijuana users or had a lifetime substance abuse/dependence or any other neurological, psychiatric, or medical illness as confirmed by medical examination and structured clinical interview. Participants drank approximately 5.4±3.1 alcoholic beverages and smoked 12.0±21.3 cigarettes per week. On scanning days, all subjects had a negative urine drug toxicology (including cannabinoids) and alcohol breathalyzer screen. All participants provided written informed consent after explanation of the protocol, as approved by the University of Chicago Institutional Review Board.

Procedure {#s4}
---------

The study was a within-subjects, double-blind, placebo-controlled design. Each participant completed 2 fMRI scan sessions (order randomized) in which they ingested an opaque gelatin capsule (size 00) with dextrose filler. The capsule contained either Δ^9^ -THC (Marinol; 7.5mg; Solvay Pharmaceuticals, Marietta, GA) or placebo (PBO; containing only dextrose). The 2 sessions occurred at least 7 days apart. Prior to scanning, participants were instructed to abstain from food for 2 hours and all drugs for 24 hours; participants were instructed to abstain from any drug for 12 hours postscanning.

Approximately 120 minutes after ingestion of the capsule, the fMRI session began. Timing of the experiment was designed to match the expected window of peak subjective effects and plasma levels of THC ([@CIT0030]). Self-report affect and drug effects were measured 30 minutes before and 30, 90, 210, and 270 minutes post-capsule ingestion using the Drug Effects Questionnaire and visual-analog scales. Participants rated the extent to which they felt the drug, liked the drug, wanted more, and felt "high." They also rated how "stimulated," "high," "anxious," and "hungry" they felt. As reported previously ([@CIT0020]), THC significantly increased ratings of "feel" drug and feeling "high" at 90, 210, and 270 minutes postingestion, corresponding to the expected timing of peak subjective THC effects.

Emotional Face Matching Task {#s5}
----------------------------

The emotional face matching task is described in detail elsewhere ([@CIT0020]) and has been used in previous pharmaco-fMRI studies to probe amygdala-frontal connectivity ([@CIT0011]). Briefly, using a block design, participants viewed a trio of faces and were asked to select from 2 faces at the bottom of the screen one that matched a target face at the top of the screen. Target faces and congruent probes displayed 1 of 3 expressions (angry, fearful, or happy), while the incongruent probe displayed a neutral expression. Face-matching trials were interspersed with a control task in which simple geometric shapes (ie, circles, rectangles, or triangles) were similarly matched. The paradigm consisted of eighteen 20-second blocks: 9 matching emotional faces (3 blocks of each target expression) plus 9 blocks matching shapes, for a total task time of 6 minutes. Expression order was counterbalanced between 2 runs, and participants responded via right-handed button press to indicate match selections. As reported in [@CIT0020], there were no main effects of THC or THC × facial expression interactions on task accuracy or response times.

Brain Imaging {#s6}
-------------

fMRI was performed on a 3T GE magnetic scanner using T2\*-sensitive gradient-echo reverse spiral acquisition images (30 axial slices, 5-mm thickness, 2-second repetition time (TR), 25-millisecond echo time (TE), 77° flip angle, 240-mm field of view (FOV), 64×64 matrix) optimized to minimize susceptibility artifacts in the amygdala.

Data Analysis {#s7}
-------------

Imaging data previously processed using Statistical Parametric Mapping software SPM2 (Wellcome Trust Centre for Neuroimaging, London, UK) were reprocessed and reanalyzed using updated SPM8 software. Images were slice-time corrected, spatially realigned, warped to standardized Montreal Neurological Institute space using the participant's mean functional image, resampled to 2-mm^3^ voxels, and smoothed with an 8-mm^3^ kernel to minimize noise and residual differences in gyral anatomy. The general linear model was sapplied to the time series and convolved with the canonical hemodynamic response function and with a 128-second high-pass filter. Condition effects were modeled separately with box-car regressors representing the occurrence of each block type (angry, fearful, happy faces, and shapes). Effects were estimated at each voxel and for each subject. Realignment parameters (ie, movement) were included in the model to account for motion-related effects. Individual contrast maps (statistical parametric maps) combining threatening stimuli (angry and fearful faces) \> shapes were created for each participant, separately for each session, and analyzed at the second level using a paired-samples *t* test. We first confirmed using a whole-brain analysis that, consistent with [@CIT0020], there was an effect of THC on left amygdala reactivity to threat (angry and fearful faces \> shapes; peak Montreal Neurological Institute coordinates: (−22, 2, −16), Z=2.50, *k* =65, *P*\<.05, small volume corrected) such that amygdala activity during threat matching was greater during PBO relative to THC.

To examine functional connectivity, we used a generalized form of context-dependent psychophysiological interaction analyses (gPPI; <http://brainmap.wisc.edu/PPI>, [@CIT0019]). Anatomical masks for left and right AMYG-BL, AMYG-CM, and AMYG-SF subregions were created using cytoarchitectonic boundaries defined by [@CIT0001] and implemented in SPM's Anatomy toolbox (see [@CIT0004]). Deconvolved time series from each mask was extracted for each subject to create the physiological variable. Condition onset times for fearful faces, angry faces, happy faces, and shapes were separately convolved with the canonical hemodynamic response function for each condition, creating psychological regressors. Interaction terms (PPIs) were computed by multiplying extracted time series from the psychological regressors with the physiological variable. Activity within each subregion was regressed on a voxel-wise basis against the interaction, with the physiological and psychological variables serving as regressors of interest. Individual contrast images for threat vs shapes were then entered into separate second-level paired-samples *t* tests.

To determine our significance threshold, we applied an anatomically derived (Automated Anatomical Labeling \[AAL\] atlas) partial brain mask of the entire PFC to our data (search volume =451840mm^3^, encompassing 56480 voxels). Cluster-based significance thresholding was used to adjust for multiple comparisons within the search volume. Based on simulations (10000 iterations) performed with 3DClustSim, an adaptation of AlphaSim (<http://afni.nimh.nih.gov/pub/dist/doc/program_help/3dClustSim.html>), a family wise error correction at α\<.05 was achieved for voxel threshold of *P*\<.005 with minimum cluster size of 156 contiguous voxels. We extracted parameter estimates/β weights representing connectivity strength (arbitrary units) from 5-mm-radius spheres surrounding peak connectivity clusters from each subject in order to conduct posthoc paired samples *t* tests to determine the direction of effects.

Results {#s8}
=======

THC altered functional coupling between left AMYG-BL and rostral ACC (rACC)/medial PFC (mPFC) \[(14, 42, 12); Z=3.65, *k*=398, *P*\<.05, corrected\] and left AMYG-SF and rACC/mPFC \[(14, 52, 6); Z=3.71, *k*=760, *P*\<.05, corrected\]. Functional connectivity in both cases was greater during THC compared with PBO ([Figure 1](#F1){ref-type="fig"}). As expected, given the lack of THC effects on right amygdala reactivity, there were no effects of THC on functional connectivity with any of the right amygdala seeds. For completeness, all other whole-brain results are presented in [Table 1](#T1){ref-type="table"}.

###### 

Whole-Brain Results for the Paired-Sample *t* Tests of gPPI Functional Connectivity for Each Amygdalasubregion

  Seed       Direction    Region                                    MNI Coordinates   Voxels     Z-Score                
  ---------- ------------ ----------------------------------------- ----------------- ---------- ---------- ----------- ------------
  Left BL    PBO \> THC   R cerebelum                               38                −42        −32        82          3.02
  Left BL    THC \> PBO   ***R Rostral anterior cingulate/mPFC***   ***14***          ***42***   ***12***   ***398***   ***3.65***
                          L superior frontal gyrus                  −18               56         4          104         3.59
  Right BL   PBO \> THC   R parietal lobe                           30                −52        70         111         2.95
  Right BL   THC \> PBO   Middle cingulate gyrus                    −2                26         −10        55          3.31
                          L inferior frontal lobe                   −46               16         18         84          3.15
  Left CM    PBO \> THC   R rectus                                  8                 32         −26        114         3.55
  Left CM    THC \> PBO   L inferior frontal lobe                   −42               22         24         180         3.21
  Right CM   PBO \> THC   L precentral gyrus                        −50               −14        58         91          3.63
                          R parietal lobe                           20                −56        78         66          3.01
  Right CM   THC \> PBO   None                                                                                          
  Left SF    PBO \> THC   R precentral gyrus                        60                10         46         117         5.19
                          L lingual gyrus                           −8                −96        −12        131         4.17
                          R superior frontal gyrus                  30                58         30         57          2.87
  Left SF    THC \> PBO   R posterior frontal lobe                  28                −38        36         456         3.90
                          ***R rostral anterior cingulate/mPFC***   ***14***          ***52***   ***6***    ***760***   ***3.71***
                          Middle cingulate gyrus                    0                 −44        42         121         3.23
                          L cingulate gyrus                         −16               −28        30         67          3.10
                          L middle frontal lobe                     −20               18         46         212         3.08
  Right SF   PBO \> THC   R superior frontal gyrus                  20                48         22         144         3.60
                          R middle temporal gyrus                   54                −56        −12        312         3.32
                          L cerebelum                               −48               −54        −28        63          3.31
                          L fusiform gyrus                          −26               −94        −24        74          3.28
                          R angular gyrus                           40                −58        30         164         3.23
                          L middle frontal gyrus                    −34               58         14         186         3.19
                          L inferior parietal lobe                  −42               −64        46         74          2.87
  Right SF   THC \> PBO   None                                                                                          

Reporting of all clusters exhibiting significance threshold at *P*\<.005(uncorrected) with a cluster extent threshold of k (number of contiguous voxels) \>50. \*Bold italics represent a priori areas of interest for significant, corrected for multiple comparisons. gPPI, generalized form of context-dependent psychophysiological interaction analyses; L, left; MNI,Montreal Neurologic Institute; mPFC, medial prefrontal cortex; PBO, placebo; R,right; SF, superficial; THC, Δ^9^-tetrahydrocannabinol.

![(A) The anatomical left basolateral amygdala (AMYG-BL) seed and a voxel-wise statistical *t* map on a canonical brain showing enhanced left AMYG-BL -- rostral anterior cingulate cortex (rACC)/medial prefrontal cortex (mPFC) functional connectivity during Δ^9^-tetrahydrocannabinol (THC) compared with placebo (PBO). Line graph illustrating extracted AMYG-BL-rACC/mPFC connectivity parameter estimates during the THC and PBO conditions. (B) The anatomical left superficial amygdala (AMYG-SF) seed and a voxel-wise statistical *t*-map on a canonical brain showing enhanced left AMYG-SF -- rACC/mPFC functional connectivity during THC compared with PBO; Line graph illustrating extracted AMYG-SF-rACC/mPFC connectivity parameter estimates during the THC and PBO conditions; LBL,left basolateral subregion; LSF,left superficial subregion.](ijnppy_pyu104_f0001){#F1}

In a separate set of analyses, identical to those discussed above, we examined the effect of THC on amygdala subregion-PFC functional connectivity during threat faces vs happy faces. Since happy faces represent a social nonthreat condition, this additional comparison allows for a test of the specificity of the present findings to social threat. Results indicated that consistent with above, THC increased left AMYG-BL to rACC/mPFC functional connectivity relative to PBO \[(12, 46, 12); *Z*=3.36, *k*=171, *P*\<.05, corrected\]. There was no effect of THC on left AMYG-SF or AMYG-CM on rACC/mPFC functional connectivity. There were also no effects of THC on any of the right amygdala subregions. Posthoc, we confirmed that there was no effect of THC on amygdala subregion-PFC functional connectivity during happy faces vs shapes. THC-induced changes in connectivity were not correlated with changes in self-reported affect and drug effects (all *P*\<.05).

Discussion {#s9}
==========

The aim of the current study was to examine the effects of THC on functional connectivity between amygdala subregions and PFC during processing of social threat in healthy, recreational cannabis users. We found that THC enhanced functional connectivity between AMYG-BL and AMYG-SF subregions and rACC/mPFC, suggesting that, in the context of threat, THC modulates amygdala reactivity and functional connectivity. Notably, our findings indicated that THC had an effect on AMYG-BL and rACC/mPFC connectivity during threatening faces relative to shapes and happy faces. This implies that AMYG-BL to rACC/mPFC functional coupling may be particularly salient for social threat rather than just general threat or just to "social" signals/faces. Consistent with our hypotheses and the design of our threat task, THC affected PFC functional coupling with the 2 amygdala subregions that are most strongly implicated in the perception, rather than the expression, of threat: the AMYG-BL and AMYG-SF. As noted above, the AMYG-BL and AMYG-SF are involved in detecting innate threat and extracting the social value of stimuli, respectively ([@CIT0004]). The direction of effects of THC on amygdala-PFC functional connectivity, relative to PBO, is noteworthy. Prior studies demonstrated that healthy individuals exhibit greater functional coupling between the amygdala and rACC/mPFC during threat ([@CIT0021]) and that greater connectivity is associated with greater affect regulation efficiency ([@CIT0002]). Thus, it is possible that enhanced functional connectivity during THC administration reflects increased rACC/mPFC regulatory influences on AMYG-BL and AMYG-SF, which could diminish threat perception and anxiety. In light of these possible relationships, future studies should explicitly test the direction of THC's effects on amygdala subregion-PFC functional coupling.

It is also possible that THC's impact on connectivity reflects broader changes in social-emotional functioning, which are independent of THC's impact on amygdala reactivity. Functional coupling between the amygdala and rACC/mPFC is implicated in a wide range of social and emotional functions, including social cognition and decision-making ([@CIT0016]). Cross-talk between these regions is necessary for determining the salience of incoming stimuli and integrating cognitive, emotional, and somatic information ([@CIT0024]). As such, increased connectivity between the AMYG-BL and AMYG-SF and the rACC/mPFC may indicate that during threat, THC enhances broad social-emotional capabilities, including extracting salience and organizing and guiding affective responses. Consistent with this explanation, a recent study found that administration of oxytocin, a neuropeptide with known prosocial effects including increasing trust and empathy ([@CIT0017]), also enhances amygdala-rACC/mPFC functional connectivity during resting-state in healthy individuals ([@CIT0022]). Meanwhile, individuals characterized by social deficits (eg, social anxiety disorder) reliably evidence abnormal functional connectivity between the amygdala and mPFC ([@CIT0013]). It is therefore possible that THC could have acute, prosocial effects, which could be potentially therapeutic for patients with social-emotional deficits.

It is important to highlight that THC impacted reactivity and functional connectivity of the left, but not the right, amygdala. Several prior studies have suggested that the left and right amygdala have separable roles in affective processes such that the right amygdala is responsible for rapid, automatic emotion detection, whereas the left amygdala is involved in sustained, conscious emotion evaluation and regulation ([@CIT0007]). Notably, this literature is consistent with the aforementioned proposed mechanisms, as affective regulation and sustained social-emotional processes are thought to be mediated by the left amygdala.

While these results significantly add to the literature on the acute neural effects of THC, there are a few limitations worth noting. First, although the study used a within-subjects design, the sample size was small, resulting in low statistical power and limited ability to detect associations between THC-inducted changes in functional connectivity and self-reported affect. Related to this point, because of the relative small sample, we did not examine moderators of the current findings, and future studies are needed to test whether individual differences could impact the pattern of results. Second, we used a relatively low dose of THC and since higher doses may have anxiogenic effects ([@CIT0029]), the findings may not generalize across doses. As such, dose-dependent THC studies are critically needed to extend this work. Similarly, all participants in the study were casual cannabis users and thus, future research is needed to determine whether the findings apply to those with less or more history of cannabis exposure. Lastly, gPPI analyses are correlational and as is noted above, studies are greatly needed to test the directionality of THC's effects on amygdala-PFC functional connectivity. This could include studies that implement Granger causality analyses or dynamic causal modeling (eg, [@CIT0031]).

In sum, the present results suggest that THC dampens amygdala reactivity and enhances AMYG-BL and AMYG-SF functional connectivity with the rACC/mPFC during the processing of threat in recreational cannabis users. These neural effects may have important affective implications, including increasing affect regulation capabilities and/or broad social-emotional processing.
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